Ms. Luksika Jiramonai | Biochemistry, Genetics and Molecular Biology | Young Scientist Award
phD at National Center for Nanoscience and Technology, China
Luksika Jiramonai is a dedicated researcher in the fields of nanoscience, biotechnology, and biomedical sciences. Currently a PhD student at the National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China, her work focuses on advancing therapeutic and diagnostic strategies in health sciences. She has a strong academic foundation with a Master’s degree in Applied Biological Sciences from Chulabhorn Graduate Institute, Thailand, and a Bachelor’s degree in Biotechnology from Mahidol University, Thailand. Over the years, Luksika has demonstrated a passion for applying her research in practical and transformative ways, particularly in the areas of disease resistance, nanotechnology, and molecular biology. With extensive research experience and an impressive track record of publications and awards, she is emerging as a promising scientist committed to solving global health challenges through innovation and scientific rigor.
Professional Profile
Education
Luksika Jiramonai has an impressive academic background, beginning with a Bachelor of Science in Biotechnology from Mahidol University, Thailand, where she explored molecular and bioprocess applications in biotechnology. She further pursued a Master of Science in Applied Biological Sciences at Chulabhorn Graduate Institute, Thailand, graduating with a cumulative GPA of 3.67/4.00. Her thesis, focused on oxidative stress responses in Stenotrophomonas maltophilia, showcases her early interest in microbiology and biotechnology. Building on this foundation, she is currently pursuing a PhD at the National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, China. Her academic journey reflects a strong focus on interdisciplinary research with an emphasis on the intersection of molecular biology, nanotechnology, and medicine. This diverse education provides a solid platform for her ongoing contributions to the field.
Professional Experience
Luksika has accumulated diverse and extensive professional experience throughout her career. From 2019 to 2022, she worked as a Research Laboratory Technician at the Malaria Laboratory, Mahidol-Oxford Research Unit, where she investigated malaria and drug resistance, playing a key role in essential research aimed at combating infectious diseases. Prior to that, she served as a Research Assistant at the Molecular Clinical Pathology Laboratory, Department of Clinical Pathology at Siriraj Hospital, Thailand, where she contributed to projects focusing on cancer and oncolytic viruses. Luksika also held a position as a Research Assistant at Chulabhorn Graduate Institute, Thailand, contributing to research on bacterial oxidative stress and antibiotic resistance. Her early experience includes an internship at SGS Thailand, where she performed standardized testing on environmental and food samples. This broad range of experience underscores her adaptability and expertise in various biomedical research areas.
Research Interests
Luksika Jiramonai’s research interests center on molecular biology, nanotechnology, and their applications in healthcare. Her current PhD research delves into the development of nanoscience-based therapeutic strategies, particularly in cancer immunotherapy and drug resistance. She has explored a variety of critical scientific fields, including bacterial oxidative stress, drug resistance mechanisms in infectious diseases like malaria, and the application of nanocrystals in drug delivery systems. Additionally, her work on atherosclerosis models and their pathophysiology demonstrates her broad interest in chronic diseases and their biomedical implications. Luksika’s interdisciplinary approach integrates molecular biology with advanced nanotechnology, and her goal is to develop more targeted, effective treatments for complex health issues. Her research aims to bridge the gap between laboratory findings and real-world medical applications, contributing to better patient outcomes through innovative scientific discoveries.
Awards and Honors
Luksika Jiramonai has received notable recognition for her contributions to scientific research. She was honored with an honorable mention at the 8th Annual Conference on “Trends in Research on Environmental Health” in Thailand, underscoring the relevance of her research in environmental health. In 2018, she was a shortlisted candidate for poster presentation at the prestigious Thailand Merck Young Scientist Award, highlighting her potential as an emerging scientist. More recently, she has authored several review articles and research papers published in respected journals such as Pharmaceutics, iScience, and Antonie van Leeuwenhoek. Her research on nanocrystals, tumor immunotherapy, and atherosclerosis models has further established her as a rising star in the scientific community. These achievements underscore her commitment to advancing science and her recognition as a researcher capable of making significant impacts in biomedical research.
Conclusion
Luksika Jiramonai appears highly suitable for the Research for Young Scientist Award. She has demonstrated strong academic credentials, significant research experience, and published work that is relevant to important health challenges. Her background in interdisciplinary research on malaria, cancer, drug resistance, and nanotechnology positions her as a promising scientist for the future.
Publications Top Noted
-
Title: Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
Authors: Luksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
Year: 2025
Journal: Pharmaceutics
DOI: 10.3390/pharmaceutics17020257
Citation: Jiramonai, L., Liang, X.-J., & Zhu, M. (2025). Extracellular Vesicle-Based Strategies for Tumor Immunotherapy. Pharmaceutics, 17(2), 257. https://doi.org/10.3390/pharmaceutics17020257 -
Title: The Development of Paliperidone Nanocrystals for the Treatment of Schizophrenia
Authors: Phattalapol Lhaglham, Luksika Jiramonai, Xing-Jie Liang, Bingchuan Liu, Fangzhou Li
Year: 2025
Journal: Progress in Biomedical Engineering
DOI: 10.1088/2516-1091/ad8fe7
Citation: Lhaglham, P., Jiramonai, L., Liang, X.-J., Liu, B., & Li, F. (2025). The Development of Paliperidone Nanocrystals for the Treatment of Schizophrenia. Progress in Biomedical Engineering, 1(1), ad8fe7. https://doi.org/10.1088/2516-1091/ad8fe7 -
Title: Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery
Authors: Phattalapol Lhaglham, Luksika Jiramonai, Yaru Jia, Baoying Huang, Yuanyu Huang, Xueyun Gao, Jinchao Zhang, Xing-Jie Liang, Mengliang Zhu
Year: 2024
Journal: iScience
DOI: 10.1016/j.isci.2024.111185
Citation: Lhaglham, P., Jiramonai, L., Jia, Y., Huang, B., Huang, Y., Gao, X., Zhang, J., Liang, X.-J., & Zhu, M. (2024). Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery. iScience, 11, 111185. https://doi.org/10.1016/j.isci.2024.111185 -
Title: Inactivation of ahpC Renders Stenotrophomonas maltophilia Resistant to the Disinfectant Hydrogen Peroxide
Authors: Nisanart Charoenlap, Luksika Jiramonai, Jurairat Chittrakanwong, Naruemon Tunsakul, Skorn Mongkolsuk, Paiboon Vattanaviboon
Year: 2019
Journal: Antonie van Leeuwenhoek
DOI: 10.1007/s10482-018-1203-9
Citation: Charoenlap, N., Jiramonai, L., Chittrakanwong, J., Tunsakul, N., Mongkolsuk, S., & Vattanaviboon, P. (2019). Inactivation of ahpC Renders Stenotrophomonas maltophilia Resistant to the Disinfectant Hydrogen Peroxide. Antonie van Leeuwenhoek, 112(5), 757-764. https://doi.org/10.1007/s10482-018-1203-9